The US Food and Drug Administration (FDA) has approved UK pharma major GSK’s Blenrep belantamab mafodotin-blmf) in ...

UK regulators have dismantled a major illicit operation producing unlicensed weight loss medicines, following a raid on a ...

US healthcare giant Johnson & Johnson today announced that the European Commission (EC) has approved the expansion for the ...

US biotech major Biogen and Chicago, Canada-based Vanqua Bio today announced a license agreement granting Biogen exclusive ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of ...

San Diego-based inflammatory diseases specialist Ventyx Biosciences announced positive results from its Phase II study of ...

US clinical-stage biotech Tango Therapeutics has announced the pricing of an underwritten offering of 21,023,337 shares of ...

French pharma major Sanofi (Euronext: SAN) reported third-quarter 2025 revenue of 12.4 billion euros ($13.2 billion), up 7% ...

Japan’s Mitsubishi Tanabe Pharma (MTPC) yesterday announced that the US Food and Drug Administration (FDA) has issued a ...

French biotech Abolis Biotechnologies has signed a strategic partnership with EUROAPI (EPA: EAPI) to develop microbial ...

The Association for Accessible Medicines (AAM) has filed for a federal injunction to prevent Connecticut from enforcing a new ...

A Swiss biotech company that applies quantum-informed science, causal biology, multi-omics and proprietary AI to early-stage ...